Grifols family to step away further from operations; enGene CEO resigns, citing health reasons

Nacho Abia

→ Spanish plasma giant Grifols will institute more big changes at the top — and the family ties have loosened considerably once again. Nacho Abia takes over for Thomas Glanzmann as CEO on April 1, while Raimon Grifols and Víctor Grifols Deu — the father-son duo who had been co-CEOs from 2017-23 — will no longer be chief corporate officer and COO, respectively. Glanzmann had held the top spot since last May and will continue as executive chairman. The moves have been brewing since 2022, according to a press release. “The Board awaited activation until the company’s post-pandemic recovery had solidified,” it says. Both members of the family will keep their seats on the board as “proprietary directors.”

Abia had served as executive officer and global chief strategy officer at Olympus Corporation and spent nearly 23…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks